181 related articles for article (PubMed ID: 2820919)
1. Plasma atrial natriuretic peptide and cyclic nucleotide levels before and after a marathon.
Lijnen P; Hespel P; M'Buyamba-Kabangu JR; Goris M; Lysens R; Vanden Eynde E; Fagard R; Amery A
J Appl Physiol (1985); 1987 Sep; 63(3):1180-4. PubMed ID: 2820919
[TBL] [Abstract][Full Text] [Related]
2. [Circadian changes of atrial natriuretic peptide, cyclic AMP, cyclic GMP, sodium, blood pressure and heart rate in normal subjects].
Xu CT; Wang YM
Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jul; 50(1):37-40. PubMed ID: 1326384
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic peptide and cyclic guanosine monophosphate plasma concentrations in patients with thyrotoxicosis and atrial fibrillation. Effect of short-term methimazole therapy.
Czekalski S; Widecka K; Gozdzik J; Ciechanowski K; Krzyzanowska-Swiniarska B; Gromniak E; Gruszczynska M
J Endocrinol Invest; 1994 May; 17(5):341-6. PubMed ID: 8077618
[TBL] [Abstract][Full Text] [Related]
4. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptide and cyclic guanosine-monophosphate in children and adolescents on peritoneal dialysis.
Bald M; Bonzel KE; Rascher W
Clin Nephrol; 1994 Jul; 42(1):50-3. PubMed ID: 7923967
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
[TBL] [Abstract][Full Text] [Related]
7. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG
J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831
[TBL] [Abstract][Full Text] [Related]
8. [Plasma levels of atrial natriuretic peptide, cyclic guanosine monophosphate and renin following 7.5% NaCl + 6% hydroxyethyl starch or Ringer's lactate. A comparative study of 6 normal subjects].
Furtwängler W; Balogh D; Pomaroli A; Koller J; Wieser C; Mair P
Anaesthesist; 1990 Oct; 39(10):499-504. PubMed ID: 1703729
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of plasma cyclic GMP and atrial natriuretic peptide after intravenous, intramuscular and subcutaneous injection of 50 micrograms hANP in man.
Osterode W; Nowotny P; Vierhapper H; Waldhäusl W
Horm Metab Res; 1995 Feb; 27(2):100-3. PubMed ID: 7759055
[TBL] [Abstract][Full Text] [Related]
10. Plasma concentrations of atrial and brain natriuretic peptides and cyclic guanosine monophosphate in response to dobutamine infusion in patients with surgically repaired tetralogy of fallot.
Hayabuchi Y; Matsuoka S; Kuroda Y
Pediatr Cardiol; 1999; 20(5):343-50. PubMed ID: 10441688
[TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic peptide and cyclic 3'5'-guanosine monophosphate as indicators of fluid volume overload in children with chronic renal failure.
Lettgen B; Bald M; Valleé H; Bonzel KE; Rascher W
Pediatr Nephrol; 1992 Jan; 6(1):60-4. PubMed ID: 1311187
[TBL] [Abstract][Full Text] [Related]
12. [Values of atrial natriuretic peptide (ANP) and cyclic guanosine monophosphate (cGMP) in cardioversion].
Lechleitner P; Genser N; Hauptlorenz S; Putensen C; Mitterschiffthaler G; Artner-Dworzak E; Puschendorf B; Dienstl F
Z Kardiol; 1991 Sep; 80(9):574-9. PubMed ID: 1661054
[TBL] [Abstract][Full Text] [Related]
13. Concomitant increase in plasma atrial natriuretic peptide and cyclic GMP during volume loading.
Weil J; Lang RE; Suttmann H; Rampf U; Bidlingmaier F; Gerzer R
Klin Wochenschr; 1985 Dec; 63(24):1265-8. PubMed ID: 3003451
[TBL] [Abstract][Full Text] [Related]
14. Plasma concentrations of cyclic 3', 5'-guanosine monophosphate in patients with cirrhosis: relationship with atrial natriuretic peptide and haemodynamics.
Kirstetter P; Moreau R; Vachiery F; Gadano A; Soupison T; Pilette C; Pussard E; Cailmail S; Takahashi H; Lebrec D
J Gastroenterol Hepatol; 1997 Mar; 12(3):233-6. PubMed ID: 9142641
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients.
Kohse KP; Feifel K; Mayer-Wehrstein R
Clin Nephrol; 1993 Aug; 40(2):83-90. PubMed ID: 8222377
[TBL] [Abstract][Full Text] [Related]
16. Discrepancy between plasma and aortic wall cyclic guanosine monophosphate in an experimental model of congestive heart failure.
Arnal JF; Hofmann F; Michel JB
Cardiovasc Res; 1993 Jun; 27(6):1094-100. PubMed ID: 8221770
[TBL] [Abstract][Full Text] [Related]
17. Plasma atrial natriuretic peptide levels in children with cardiac diseases: correlation with cGMP levels and haemodynamic parameters.
Weil J; Strom TM; Brangenberg R; Sebening W; Haufe M; Lang RE; Bidlingmaier F; Gerzer R
Horm Res; 1987; 28(1):64-70. PubMed ID: 2834283
[TBL] [Abstract][Full Text] [Related]
18. Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure.
Tsutamoto T; Kanamori T; Wada A; Kinoshita M
J Am Coll Cardiol; 1992 Sep; 20(3):541-6. PubMed ID: 1324959
[TBL] [Abstract][Full Text] [Related]
19. Increased plasma cyclic guanosine monophosphate concentrations in children with high levels of circulating atrial natriuretic peptide.
Weil J; Gerzer R; Strom T; Lang RE; Döhlemann C; Knorr D; Bidlingmaier F
Pediatrics; 1987 Oct; 80(4):545-8. PubMed ID: 2821478
[TBL] [Abstract][Full Text] [Related]
20. Relationship between plasma levels of atrial natriuretic peptide and cyclic guanosine monophosphate in patients with heart diseases.
Nakaoka H; Imataka K; Kitahara Y; Fujii J; Ishibashi M; Yamaji T
Jpn Circ J; 1988 Jan; 52(1):30-4. PubMed ID: 2834571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
